A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years

Summary

The goal of this clinical trial is to learn whether DEP114 is effective in treating acute exacerbations of persistent allergic rhinitis in children aged 6 to less than 12 years. The study will also evaluate the safety of DEP114. Participants will: * Take DEP114 or desloratadine once daily for 5 days (up to a maximum of 7 days). * Keep a diary of their symptoms.

Timeline

Start

2027-06

Primary completion

2028-12

Completion

2028-12

Drugs

Indications